CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Entrada Therapeutics, Inc. (TRDA) Reports Q2 Loss, Tops Revenue Estimates

EarningsPositive
AI Analysis

Summary

Entrada Therapeutics reported Q2 earnings with a net loss but revenue that exceeded analyst estimates.

Financial Highlights

Revenue

topped estimates

Importance:3/10
Sentiment:
0.30
earningsQ2 resultsrevenue
Related Companies

Read the original article

Published by yahoo_finance on August 5, 2026 1:00 PM

Read Original